Although this assay was intended to detect single-nucleotide variants and small insertions and deletions (indels) in cancer relevant genes, a read depth (>5000×, reference mean 1135×) suggestive of a focal amplification was noted at the FGFR2 locus, a SCNA that is considered medically actionable in other cancer types. This evidence concerns the gene FGFR2 and cancer.